Immunotherapy | St. Louis Public Radio

Immunotherapy

Washington University's Siteman Cancer Center offers patients with certain blood cancers a new gene-altering therapy that uses the immune system to attack cancer cells.
Provided by Washington University in St. Louis

The U.S. Food and Drug Administration last week approved a drug that genetically modifies a patient's immune cells to attack cancer cells. Washington University's Siteman Cancer Center at Barnes-Jewish Hospital is among the first medical centers to offer the treatment, which is aimed at helping those with non-Hodgkin's lymphoma and some types of blood cancers. 

Yescarta, manufactured by California-based Kite Pharmaceuticals, is part of a new wave of drugs that use the immune system to fight cancer, also known as immunotherapy.